Delhi HC Allows Zydus to Sell Cheaper Cancer Drug Biosimilar
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
TMC MP Mahua Moitra's comments on Hinduism, Hindutva, and 'love jihad' at a Calcutta Club debate trigger a fierce political clash. BJP MP Sudhanshu Trivedi counters. Read the full debate details.
Calcutta High Court dissolves a marriage, ruling that rare 'blue moon' visits don't constitute conjugal life. The court applied the irretrievable breakdown as cruelty under the Special Marriage Act. Read the full judgment details.
A viral tweet sparks fierce debate on X about arranged marriages in India. Explore the clash between tradition, caste, gender roles, and the rise of hybrid unions. What does Gen Z want?
Hingoli district collector Rahul Gupta mandates priests, caterers, and all wedding service providers to verify age, holding them liable as co-accused for facilitating child marriages. Read the strict new directives.
The Maharashtra zonal round of the national Speak for India debate competition was held at MIT Academy of Engineering, Pune. Students from top colleges showcased oratory skills for cash prizes up to Rs 2.5 lakh. Read more about the vibrant intellectual ev
Kerala High Court directs Alappuzha registrar to issue a marriage certificate with a woman's new name within a month, a key step for her UAE family visa. Read the full legal journey.
Calcutta High Court upholds divorce based on desertion, ruling it carries more weight than cruelty in marriages broken beyond repair. Key insights from the landmark judgment explained.
Actress Gautami Kapoor strongly disagrees with Kajol and Twinkle Khanna's take on physical infidelity. She calls disloyalty a deal-breaker. Read her full interview response here.
Tata Steel books first bulk shipment from Canada to hedge against captive mine expiries in 2030. A strategic move to secure raw material supply and explore future options. Read more.
Meesho's shares fell 5% after a lock-in period ended, releasing 110 million shares. Major brokerages like UBS remain optimistic, citing strong growth potential in India's mass market. Read the full analysis.
Meesho shares fell 5% as a 1-month lock-in for pre-IPO investors ended, making 109.9 million shares eligible for trade. Analysts cite increased supply and high valuations for the pressure.
Maharashtra's top college debaters dazzled at the Speak for India zonal round in Aurangabad. Winners now compete for a Rs 2.5 lakh cash prize in the national finals. Read about the intellectual showdown.
A massive $45 billion worth of IPO lock-in periods are set to expire for 96 Indian companies between Jan 6 and Apr 30. Learn which stocks are affected and how it could impact prices.
A massive $45 billion worth of IPO lock-in expiries are set to hit Indian markets in coming months, potentially triggering volatility. Nuvama warns of pressure on specific stocks. Read the full analysis.
Podcaster Clavicular faces backlash for claiming high sexual partner count diminishes oxytocin bonding. His viral comments on 'One Night with Steiny' fuel a fierce debate on modern relationships. Read the full story.
Tired of marital disconnect? A New York divorce lawyer reveals a simple weekly ritual—the 'walk and talk'—that rebuilds emotional bonds and can even stop a divorce. Learn the easy steps.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Canada faces a surge in undocumented immigrants as work permits expire. With nearly half from India, expert Kanwar Seirah warns of social impact. Learn the critical details.
Tesla's global EV crown slips to China's BYD after a 9% delivery drop in 2025. Intense competition and expiring US tax credits hit sales. Can Musk's robotaxi and robotics pivot revive fortunes? Read the full analysis.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Food safety officials in Noida seized over 42 kg of Italian bread lacking expiry dates from a major sandwich chain. The crackdown is part of pre-New Year inspections across GB Nagar. Read for details.
CBSE postpones exams scheduled for March 3, 2026. Class 10 papers move to March 11, Class 12 Legal Studies to April 10. Check the new dates and official notice here.
Indian stock markets consolidate amid F&O expiry and profit booking. Gold prices correct sharply by ₹5,000, Bitcoin slips ₹55,000. Experts share Nifty, Bank Nifty outlook and 8 stock picks for today.
Indian stock markets are set to end 2025 with double-digit gains despite a tough year. With two sessions left, experts predict consolidation and advise selective, value-focused investing for 2026.
MP WCD officials investigated an anonymous complaint about minors at an Indore mass wedding of 242 couples. Organizers claim screening prevented underage participation. Details inside.
Indian equity benchmarks opened flat on Thursday with low volumes as the year draws to a close. Analysts warn of potential volatility due to the monthly F&O expiry. Key sectors and stocks in focus.
Indian stock markets brace for a cautious final week of 2025 as FPIs and prop traders build significant bearish positions. Nifty expected to trade sideways with a bearish bias amid thin holiday volumes. Key details inside.